The incidence of CMV replication did not reach statistical significance according to the use of antiviral prophylaxis: 35% (95 of 271) in patients not receiving CMV prophylaxis and 43.7% (93 of 213) in those given prophylaxis ( P = .060).
← all excerpts
Impacts of Interleukin-18 Polymorphisms on the Incidence of Delayed-Onset Cytomegalovirus Infection in a Cohort of Kidney Transplant Recipients.
1
0.0600
0.0600